Correction to: Cell Death Discovery (2017) 3, 17021; doi:10.1038/cddiscovery.2017.21; published online 15 May 2017
Since the publication of this paper, the authors realised that they had not included the funding information for the work. The necessary funding information is as follows:
This work was supported by the National Natural Science Foundation of China, Beijing, China (81470611, 81530027, and 81471554); the National Basic Research Program of China, Beijing, China (2013CB967004); the Taishan Scholar Program Phase II, Jinan, China (ts20150215); the Shandong Province Key Research and Development Program, Jinan, China (2015GGH318010); the Innovation Project of Shandong Academy of Medical Sciences; and the Shenzhen Municipal Science and Technology Innovation Committee (JCYJ20160531185449995).
The authors apologise for this error.
The html and pdf versions have been rectified, and now carry the corrected paper.
Additional information
The online version of the original article can be found at 10.1038/cddiscovery.2017.21
Rights and permissions
This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
About this article
Cite this article
Wang, T., Li, F., Geng, W. et al. Erratum: MicroRNA-122 ameliorates corneal allograft rejection through the downregulation of its target CPEB1. Cell Death Discov. 3, 17046 (2017). https://doi.org/10.1038/cddiscovery.2017.46
Published:
DOI: https://doi.org/10.1038/cddiscovery.2017.46
